COMBINATION THERAPIES WITH ANTI-CD38 ANTIBODIES AND PARP OR ADENOSINE RECEPTOR INHIBITORS

This invention relates to methods and compositions for treating a disease by administering a combination therapy comprising an anti- CD38 antibody and a poly ADR ribose polymerase inhibitor (PARPi); an anti-CD38 antibody and an adenosine receptor antagonist; or an anti- CD38 antibody, a PARPi and an...

Full description

Saved in:
Bibliographic Details
Main Author ARIAS Diana Alvarez
Format Patent
LanguageEnglish
Spanish
Published 14.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention relates to methods and compositions for treating a disease by administering a combination therapy comprising an anti- CD38 antibody and a poly ADR ribose polymerase inhibitor (PARPi); an anti-CD38 antibody and an adenosine receptor antagonist; or an anti- CD38 antibody, a PARPi and an adenosine receptor antagonist, to a subject (e.g., a human patient) in need thereof. Esta invención se relaciona con métodos y composiciones para tratar una enfermedad al administrar una terapia de combinación que comprende un anticuerpo anti-CD38 y un inhibidor de poli ADP ribosa polimerasa (PARPi); un anticuerpo anti-CD38 y un antagonista del receptor de adenosina o un anticuerpo anti-CD38, un PARPi y un antagonista del receptor de adenosina, a un sujeto (p. ej., un paciente humano) que lo necesite.
Bibliography:Application Number: MX20230009769